In their analysis of RA patients with cardiovascular disease, Hong and coauthors [101] showed a non-significant reduction of the risk of osteoporotic vertebral fractures induced by the application of TNF-α inhibitors. This evidence concerns the gene TNF and rheumatoid arthritis.